# Nalbuphine Dosing and Its Impact on Anxiety and Depression in Ectopic Pregnancy Surgery

> **NCT07009808** · NA · NOT_YET_RECRUITING · sponsor: **Chengdu Jinjiang Maternity and Child Health Hospital** · enrollment: 165 (estimated)

## Conditions studied

- Ectopic Pregnancy
- Anxiety
- Depression
- Nalbuphine

## Interventions

- **DRUG:** Nalbuphine 0.20mg/ml(total 30 mg)
- **DRUG:** Nalbuphine 0.27mg/ml(total 40 mg)
- **DRUG:** Nalbuphine 0.33mg/ml(total 50 mg)

## Key facts

- **NCT ID:** NCT07009808
- **Lead sponsor:** Chengdu Jinjiang Maternity and Child Health Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-06-20
- **Primary completion:** 2025-10-22
- **Final completion:** 2025-10-30
- **Target enrollment:** 165 (ESTIMATED)
- **Last updated:** 2025-06-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07009808

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07009808, "Nalbuphine Dosing and Its Impact on Anxiety and Depression in Ectopic Pregnancy Surgery". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07009808. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*